Prostaglandin E2 Tablets Prevent Aspirin-induced Blood Loss in Man

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 1982 Nov 1

PMID 6982803

Citations 4

Authors

K Y Yik

A A Dreidger

W C Watson

Affiliations

Soon will be listed here.

Abstract

A double-blind study was performed to determine the effect of prostaglandin E2 (PGE2) tablets on aspirin-induced blood loss in 20 healthy male volunteers. All subjects took aspirin, and 9 in the control group and 11 in the treatment group received placebo and PGE2 respectively. One tablet of PGE2, 0.5 mg, was given four times daily for five days. Two tablets of unbuffered aspirin (640 mg) were given four times daily for four days commencing one day after the start of the PGE2 or placebo. Fecal blood loss was measured using 51Cr-labeled red cells. There was no significant difference in serum salicylate levels. There was a significant increase in fecal blood loss in control subjects on the third and fourth days on aspirin and for 4 days following aspirin ingestion. In the treatment group, fecal blood loss was prevented by PGE2.

Citing Articles

The effect of tiaprofenic acid and indomethacin on in vitro prostaglandin synthesis by rat, rabbit and human stomach tissue.

Jeremy J, Mikhailidis D, Dandona P Agents Actions. 1985; 17(2):205-8.

PMID: 4096305 DOI: 10.1007/BF01966593.

Cigarette smoke extracts inhibit prostacyclin synthesis by the rat urinary bladder.

Jeremy J, Mikhailidis D, Dandona P Br J Cancer. 1985; 51(6):837-42.

PMID: 3890913 PMC: 1977078. DOI: 10.1038/bjc.1985.129.

Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs.

McCormack K, Brune K Arch Toxicol. 1987; 60(4):261-9.

PMID: 3307703 DOI: 10.1007/BF01234664.

A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.

Lanza F Dig Dis Sci. 1986; 31(2 Suppl):131S-136S.

PMID: 3080285 DOI: 10.1007/BF01309338.

References

Karim S, Filshie G . The use of prostaglandin E 2 for therapeutic abortion. J Obstet Gynaecol Br Commonw. 1972; 79(1):1-13. DOI: 10.1111/j.1471-0528.1972.tb15740.x. View

Miller T, Jacobson E . Gastrointestinal cytoprotection by prostaglandins. Gut. 1979; 20(1):75-87. PMC: 1418958. DOI: 10.1136/gut.20.1.75. View

Bolton J, Palmer D, COHEN M . Effect of the E2 prostaglandins on gastric mucus production in rats. Surg Forum. 1976; 27(62):402-3. View

Goulston K, Cooke A . Alcohol, aspirin, and gastrointestinal bleeding. Br Med J. 1968; 4(5632):664-5. PMC: 1912769. DOI: 10.1136/bmj.4.5632.664. View

Karim S, Sharma S . Oral administration of prostaglandins for the induction of labour. Br Med J. 1971; 1(5743):260-2. PMC: 1794953. DOI: 10.1136/bmj.1.5743.260. View

Bolton J, Palmer D, COHEN M . Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Am J Dig Dis. 1978; 23(4):359-64. DOI: 10.1007/BF01072421. View

GROSSMAN M, MATSUMOTO K, LICHTER R . Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology. 1961; 40:383-8. View

Robert A . Cytoprotection by prostaglandins. Gastroenterology. 1979; 77(4 Pt 1):761-7. View

CROFT D, WOOD P . Gastric mucosa and susceptibility to occult gastrointestinal bleeding caused by aspirin. Br Med J. 1967; 1(5533):137-41. PMC: 1840577. DOI: 10.1136/bmj.1.5533.137. View

10.

Karim S . Action of prostaglandin in the pregnant woman. Ann N Y Acad Sci. 1971; 180:483-98. DOI: 10.1111/j.1749-6632.1971.tb53216.x. View

11.

Karim S . Effects of oral administration of prostaglandins E 2 and F 2- on the human uterus. J Obstet Gynaecol Br Commonw. 1971; 78(4):289-93. DOI: 10.1111/j.1471-0528.1971.tb00274.x. View

12.

LANGE H . Salicylates and gastric hemorrhage. I. Occult bleeding. Gastroenterology. 1957; 33(5):770-7. View

13.

Chaudhury T, Jacobson E . Prostaglandin cytoprotection of gastric mucosa. Gastroenterology. 1978; 74(1):58-63. View

14.

Robert A . Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res. 1976; 2:507-20. View

15.

Johansson C, Kollberg B, Nordemar R, Samuelson K, Bergstrom S . Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology. 1980; 78(3):479-83. View

16.

Johansson C, Kollberg B, Nordemar R, Bergstrom S . Mucosal protection by prostaglandin E2. Lancet. 1979; 1(8111):317. DOI: 10.1016/s0140-6736(79)90723-2. View

17.

Thiery M, Sian A, De Hemptinne D, DEROM R, Martens C, Van Kets H . Induction of labour with prostaglandin E2 tablets. J Obstet Gynaecol Br Commonw. 1974; 81(4):303-6. DOI: 10.1111/j.1471-0528.1974.tb00464.x. View

18.

EBAUGH Jr F, CLEMENS Jr T, RODNAN G, Peterson R . Quantitative measurement of gastrointestinal blood loss. I. The use of radioactive Cr51 in patients with gastrointestinal hemorrhage. Am J Med. 1958; 25(2):169-81. DOI: 10.1016/0002-9343(58)90024-x. View

19.

Karim S, Carter D, Bhana D, Ganesan P . Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion. Br Med J. 1973; 1(5846):143-6. PMC: 1588413. DOI: 10.1136/bmj.1.5846.143. View

20.

COHEN M, Cheung G, Lyster D . Prevention of aspirin-induced faecal blood loss by prostaglandin E2. Gut. 1980; 21(7):602-6. PMC: 1419893. DOI: 10.1136/gut.21.7.602. View